Acute and chronic pain remain significant health problems despite tremendous progress in the understanding of their basic mechanisms. Studies conducted using intact animals allow the examination of the multidimensional nature of pain. Aragen has established a range of animal models to support the evaluation of novel drug candidates for inflammatory, neuropathic, and cancer-related pain.
